2015 – Hair loss and baldness reports acknowledged by FDA

Announcement Date: December 1, 2015

FDA acknowledges reports of permanent hair loss and baldness in chemotherapy patients treated with Taxotere. The agency’s announcement preceded a label change for the product, noting the possibility of permanent hair loss.